Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha
出版年份 2013 全文链接
标题
Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 4, Pages 988-996
出版商
Wiley
发表日期
2013-08-12
DOI
10.1002/ijc.28427
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acute promyelocytic leukemia, arsenic, and PML bodies
- (2012) Hugues de Thé et al. JOURNAL OF CELL BIOLOGY
- CD27 signaling on chronic myelogenous leukemia stem cells activates Wnt target genes and promotes disease progression
- (2012) Christian Schürch et al. JOURNAL OF CLINICAL INVESTIGATION
- Leucémie myéloïde chronique : « archétype » de l’impact des traitements ciblés
- (2012) R. Nasr et al. PATHOLOGIE BIOLOGIE
- BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet
- (2011) S. Soverini et al. BLOOD
- How I treat adult T-cell leukemia/lymphoma
- (2011) A. Bazarbachi et al. BLOOD
- Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment
- (2011) S. Chu et al. BLOOD
- From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia
- (2011) S.-J. Chen et al. BLOOD
- Kill one bird with two stones: potential efficacy of BCR-ABL and autophagy inhibition in CML
- (2011) G. V. Helgason et al. BLOOD
- Curing APL through PML/RARA degradation by As2O3
- (2011) Valerie Lallemand-Breitenbach et al. TRENDS IN MOLECULAR MEDICINE
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- The response to imatinib and interferon- is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase
- (2010) F. Palandri et al. HAEMATOLOGICA
- Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting
- (2010) Rihab Nasr et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity
- (2010) Amie S. Corbin et al. JOURNAL OF CLINICAL INVESTIGATION
- Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
- (2010) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia
- (2010) Hiba El Hajj et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Successful imatinib and arsenic trioxide combination therapy for sudden onset promyelocytic crisis with t(15;17) in chronic myeloid leukemia
- (2010) Makoto Kashimura et al. LEUKEMIA RESEARCH
- Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone
- (2010) Franck E. Nicolini et al. LEUKEMIA RESEARCH
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- As4S4 targets RING-type E3 ligase c-CBL to induce degradation of BCR-ABL in chronic myelogenous leukemia
- (2010) J.-H. Mao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PML Nuclear Bodies
- (2010) V. Lallemand-Breitenbach et al. Cold Spring Harbor Perspectives in Biology
- Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
- (2009) G. Kchour et al. BLOOD
- Therapy-induced PML/RARA Proteolysis and Acute Promyelocytic Leukemia Cure
- (2009) R. Nasr et al. CLINICAL CANCER RESEARCH
- Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet
- (2009) Michele Baccarani et al. JOURNAL OF CLINICAL ONCOLOGY
- IFNα activates dormant haematopoietic stem cells in vivo
- (2009) Marieke A. G. Essers et al. NATURE
- The tumor suppressor Pml regulates cell fate in the developing neocortex
- (2009) Tarik Regad et al. NATURE NEUROSCIENCE
- Therapeutic Options Against BCR-ABL1 T315I-Positive Chronic Myelogenous Leukemia
- (2008) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
- PML targeting eradicates quiescent leukaemia-initiating cells
- (2008) Keisuke Ito et al. NATURE
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
- Therapy Options in Imatinib Failures
- (2008) P. Ramirez et al. ONCOLOGIST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now